Investing.com -- Morgan Stanley (NYSE: MS) upgraded its rating on Zealand Pharma (NASDAQ: ZEAL) shares to Overweight from ...
For more on Immunovant’s new data, go here; for more on Sarepta’s gene therapy, go here; to learn more about Zealand’s deal with Roche, go here; and to read about the panels at our Breakthrough East ...
20hon MSN
The United States pharmaceutical lobby has complained to US President Donald Trump that Australia’s Pharmaceutical Benefits ...
The United States pharmaceutical lobby has complained to US President Donald Trump that Australia's Pharmaceutical Benefits ...
Fierce Biotech Layoff Tracker 2025: Elevation eliminates 70% of staff; bit.bio cuts 25% of workforce
Story March 17 - Merck & Co.: The big pharma is planning to cut 163 jobs at its Cherokee manufacturing plant in Riverside, Pennsylvania, as part of a multi-year plan to wind down operations at the ...
Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 14,337.75 Crore) operating in Pharmaceuticals sector. Natco Pharma Ltd. key Products/Revenue Segments ...
Whether you’re a fan of the All Blacks, a follower of the women’s game or someone who watches every phase of play in the Premiership, our rugby features and news pieces will provide you with all of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results